RefBan

Referral Banners

Yashi

Tuesday, May 6, 2014

Reuters Health Report

Click to View in Browser
05/6/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Merck & Co sells consumer unit to Bayer for $14 billion
(Reuters) - Merck & Co Inc has agreed to sell its consumer care business to Germany's Bayer AG for $14.2 billion, the companies said on Tuesday, adding to a string of major cross-border healthcare deals.
Genome scientist Craig Venter in deal to make humanized pig organs
CHICAGO (Reuters) - Genome pioneer J. Craig Venter is teaming up with a unit of United Therapeutics Corp to develop pig lungs that have been genetically altered to be compatible with humans, a feat that, if successful, could address the urgent need for transplant organs for people with end-stage lung disease.
Senegal re-opens border with Guinea as Ebola threat eases
DAKAR (Reuters) - Senegal reopened its border with Guinea on Tuesday, over a month after it sealed land crossings with its southern neighbor to try to prevent the spread of the Ebola virus that has killed dozens in Guinea.
Astra gets lift in Pfizer fight as U.S. okays heart pill
LONDON (Reuters) - AstraZeneca Plc has won U.S. approval for Epanova, a new pill for heart disease, providing a welcome - but relatively minor - piece of good news as it fights a $106 billion takeover approach from Pfizer Inc.
Novartis says Signifor LAR drug helps control acromegaly disease
ZURICH (Reuters) - Swiss drugmaker Novartis said on Monday a final-stage trial of its Signifor LAR therapy allowed for greater disease control in patients with the endocrine disorder acromegaly than existing therapies.
Deaths fell after Massachusetts healthcare overhaul: study
NEW YORK (Reuters Health) - When Massachusetts blazed the trail of healthcare reform in 2006 by expanding coverage for the poor and requiring all residents to have health insurance, it may have done more than serve as a model for nationwide reform: it also seemed to save lives, according to a study released on Monday.
Mothers can hold newborns before umbilical cord is clamped: study
NEW YORK (Reuters Health) - Newborn babies don't need to be held down around their mother's vagina while the last of the placental blood makes its way through the umbilical cord, according to a new study.
Coke to remove controversial chemical from Fanta, other drinks
NEW YORK (Reuters) - The Coca-Cola Company said on Monday it will remove a controversial flavoring stabilizer from some of its drinks, following rival PepsiCo Inc's announcement earlier this year that it would drop the same ingredient from its drinks.
FDA questions use of aspirin to prevent first heart attack
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Monday questioned the value of taking aspirin to try to ward off a first heart attack or stroke in people who have never had cardiovascular problems.
All workers test negative for MERS at Indiana hospital-official
MUNSTER Ind. (Reuters) - All workers at the Indiana hospital where the first U.S. case of the often deadly Middle East Respiratory Syndrome was confirmed last week have tested negative for the virus, officials at Community Hospital in Munster, Indiana, said on Monday.
Related Video
Rotting, bloated Blue whale worries Canadian fishing community
Elephant dung recycled into 'poo paper'
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika